Intracavitary therapy of noninvasive transitional cell carcinomas of the upper urinary tract: A review of the literature

Urologia Internationalis

Volumn 67, Issue 3, 2001, Pages 189-194

  Bassi, PierFrancesco ^a   Iafrate, M ^a   Longo, F ^a   Iannello, A ^a   Mostaccio, G ^a   Ingrassia, A ^a   Repele, M ^a   Tavolini, I M ^a  

^a Monoblocco Ospedaliero   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; MITOMYCIN C; THIOTEPA; TUBERCULOSTATIC AGENT;

ADJUVANT CHEMOTHERAPY; BLADDER DYSFUNCTION; CANCER STAGING; CARCINOMA IN SITU; CONSERVATIVE TREATMENT; DEATH; EMERGENCY TREATMENT; FEVER; HEMATURIA; HUMAN; HYPOTENSION; MALAISE; MENTAL DISEASE; OLIGURIA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TRANSITIONAL CELL CARCINOMA; URETER OBSTRUCTION; URINARY TRACT; UROGENITAL TRACT TUMOR; UROLOGY;

ADJUVANTS, IMMUNOLOGIC; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; HUMANS; KIDNEY NEOPLASMS; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0035742121     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050985     Document Type: Review

References (52)

1. Treatment options for upper tract transitional-cell carcinoma
2. Intrarenal bacillus Calmette-Guérin therapy for upper urinary tract carcinoma in situ
3. Conservative surgery for transitional cell carcinoma of the renal pelvis
4. Endourologic treatment of transitional cell carcinoma of the upper urinary tract
5. Ureteroscopic treatment of urothelial carcinoma of the ureter and renal pelvis
6. Endourological management of upper tract urothelial tumors
7. Conservative management of transitional cell carcinoma of the kidney and ureter
8. Endourological treatment of upper tract urothelial carcinomas: Analysis of a series of 59 tumors
9. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma
10. Percutaneous management of grade II upper urinary tract transitional cell carcinoma: The long-term outcome
11. Primary percutaneous approach to upper urinary tract transitional cell carcinoma
12. Local excision in transitional cell tumors of the upper urinary tract
13. Upper tract transitional cell carcinoma
14. Management of transitional cell carcinoma of the upper urinary tract: Case for conservative local excision
15. Bilateral primary carcinoma of the ureter: Topical intraureteral thiotepa
16. Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors
17. Treatment of superficial papillary transitional cell carcinoma of the ureter by vesicoureteral reflux of mitomycin C
18. Adjuvant mitomycin C instillation in the treatment of upper tract transitional cell carcinoma
19. Instillation of bacillus Calmette-Guérin into the renal pelvis of a solitary kidney for the treatment of transitional cell carcinoma
20. Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience
21. Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumor
22. Experience with bacillus Calmette-Guérin in patients with superficial bladder carcinoma
23. Effect of intravesical bacillus Calmette-Guérin (BCG) on carcinoma in situ of the bladder
24. Long-term results and complications of intracavitary bacillus Calmette-Guérin therapy for bladder cancer
25. The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guérin
26. Bacillus Calmette-Guérin immunotherapy for bladder
27. Bacillus Calmette-Guérin in the management of bladder cancer
28. Carcinoma in situ of the bladder
29. Intravesical therapy of bladder cancer: An immunotherapy success story
30. Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guérin
31. Percutaneous management of renal pelvic tumors: A treatment option in selected cases
32. Percutaneous bacillus Calmette-Guérin perfusion of the upper urinary tract for carcinoma in situ
33. The management of transitional cell carcinoma in solitary renal units
34. Tollerabilità di un trattamento topico percutaneo con bacillo di Calmette-Guérin delle neoplasie transizionali superficiali delle alte vie urinarie
35. Trattamento topico percutaneo con bacillo di Calmette-Guérin delle neoplasie superficiale delle alte vie urinarie: Indicazioni, modalità e tollerabilità
36. New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma
37. Bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract
38. Intrarenal bacillus Calmette-Guérin therapy for carcinoma in situ of the upper urinary tract
39. Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract
40. Bacillus Calmette-Guérin instillation treatment for carcinoma in situ of the upper urinary tract
41. Percutaneous bacillus Calmette-Guérin perfusion of the upper urinary tract carcinoma in situ
42. Pyeloscopy in urothelial tumors
43. The effect of bacillus Calmette-Guérin on the urinary system of pigs
44. The effect of intravesical bacillus Calmette-Guérin therapy on the upper urinary tract
45. Bacillus Calmette-Guérin treatment and vesicorenal reflux
46. Complications of intracavitary bacillus Calmette-Guérin after percutaneous resection of upper tract transitional cell carcinoma
47. Fever following intracavitary bacillus Calmette-Guérin therapy for upper urinary tract transitional cell carcinoma
48. Granulomatous nephritis as a complication of intrarenal bacille Calmette-Guérin therapy
49. The use of intravesical thiotepa in the management of non invasive carcinoma of the bladder
50. Local excision and topical thiotepa in the treatment of transitional cell carcinoma of the renal pelvis: A case report
51. Overview on mitomycin C in superficial bladder cancer
52. Treatment of urothelial carcinoma of the upper urinary tract following prostacystectomy with mitomycin C instillation in the ileal loop